Related Experiment Videos
Hyperinsulinaemia causes a preferential increase in hepatic P4501A2 activity.
C R Barnett1, J Wilson, C R Wolf
1Division of Toxicology, School of Biological Sciences, University of Surrey, Guildford, Northern Ireland.
Biochemical Pharmacology
|March 17, 1992
Summary
Rats with insulinomas showed increased P4501A2 activity, linked to high insulin levels. Insulin administration also boosted P4501A2 activity, suggesting hyperinsulinemia drives this effect in drug metabolism.
Area of Science:
- Biochemistry
- Pharmacology
- Toxicology
Background:
- Insulinoma causes severe hypoglycemia and hyperinsulinemia.
- Hepatic enzyme activity and drug metabolism can be altered by disease states.
Purpose of the Study:
- To investigate the impact of insulinoma-induced hyperinsulinemia on hepatic enzyme activity and drug metabolism in rats.
- To determine if insulin administration affects these metabolic pathways.
Main Methods:
- Rats with transplanted insulinomas were compared to control rats.
- Hepatic enzyme activities (O-deethylation, N-demethylation) and mutagen activation (Ames test) were measured.
- Hepatic P4501A2 and P4503A1 apoprotein levels were assessed using immunoblot analysis.
- Insulin was administered to Wistar rats to observe its effects.
Main Results:
- Insulinoma-bearing rats exhibited higher hepatic O-deethylation and N-demethylation activities.
- These rats showed enhanced conversion of a promutagen (Glu-P-1) to mutagenic intermediates.
- Hepatic P4501A2 apoprotein levels were significantly elevated in insulinoma-bearing rats.
- Insulin administration to Wistar rats increased P4501A2 activity and Glu-P-1 activation.
Conclusions:
- Hyperinsulinemia associated with insulinoma leads to increased hepatic P4501A2 activity.
- Insulin itself can enhance P4501A2 activity, likely mediated by hyperinsulinemia.
- These findings highlight the role of insulin in modulating drug-metabolizing enzymes.